Deutsche Bank’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Deutsche Bank’s Portfolio CADX Stock Details CADX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-72,250	Closed	-$653K	–	6008
2013 Q4	$653K	Sell	72,250 -72,345	-50%	-$522K	﹤0.01%	2914
2013 Q3	$909K	Buy	144,595 +33,165	+30%	+$211K	﹤0.01%	3049
2013 Q2	$758K	Buy	+111,430	New	+$776K	﹤0.01%	2884

Other funds holding CADX

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank's CADX Position: Q1 2014 in Review

Deutsche Bank sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 72,250 shares — an estimated $653K sold.

Deutsche Bank first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $909K in Q3 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

Deutsche Bank reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
Deutsche Bank sold 72,250 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $653K.
Deutsche Bank first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
Deutsche Bank's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $909K in Q3 2013.
3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Deutsche Bank's 13F filing for Q1 2014, filed 15 May 2014.